US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Zomedica Corp. Common Shares
(NY:
ZOM
)
0.0973
UNCHANGED
Last Price
Updated: 8:00 PM EST, Mar 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zomedica Corp. Common Shares
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022
January 27, 2022
ANN ARBOR, MI / ACCESSWIRE / January 27, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
Zomedica Stock Should Have Popped on This Latest Acquisition, so Beware
↗
January 21, 2022
So when an intriguing acquisition has failed to boost ZOM stock, investors should ask why that’s the case.
Via
InvestorPlace
Zomedica CEO Provides Update to Shareholders
January 10, 2022
ANN ARBOR, MI / ACCESSWIRE / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion...
From
Zomedica Corp.
Via
AccessWire
3 Most-Shorted Stocks at 52-Week Lows to Buy
↗
January 07, 2022
In a market made up of stocks, these three most-shorted stocks look poised to deliver a much happier 2022 to bullish investors.
Via
InvestorPlace
There’s a Reason to Consider Buying Zomedica, and It’s a Real Shocker
↗
January 07, 2022
ZOM stock is far from a market darling, but an underreported acquisition could breathe new life into Zomedia's struggling business.
Via
InvestorPlace
Zomedica Stock Soars After $71M Pulse Veterinary Acquisition
↗
October 01, 2021
Zomedica Corp (NYSE:ZOM) has acquired the
Via
Benzinga
Zomedica Remains a Speculative Play in the Veterinary Field
↗
January 04, 2022
The dismal run of ZOM Stock likely to continue for the foreseeable future, until it meaningfully improves its top and bottom-line numbers.
Via
InvestorPlace
Analysis: Robinhood's 2 Top Losers From Its 'Most Popular' Watchlist
↗
December 31, 2021
Centro Electric Group Ltd. (NASDAQ:NAKD) and Zomed...
Via
Benzinga
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
↗
December 16, 2021
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022.
Via
InvestorPlace
Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference
December 15, 2021
ANN ARBOR, MI / ACCESSWIRE / December 15, 2021 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals,...
From
Zomedica Corp.
Via
AccessWire
7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out
↗
December 09, 2021
Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.
Via
InvestorPlace
Topics
Economy
Penny Stocks to Watch: What’s Going on With ZOM, DARE, PSFE, EFOI and AUUD Today?
↗
December 08, 2021
Penny stocks are still a hot topic among retail traders and we're covering some of the top ones to watch Wednesday that are on the move.
Via
InvestorPlace
22 Stocks Moving in Wednesday's Pre-Market Session
↗
December 08, 2021
Gainers Daré Bioscience, Inc. (NASDAQ: DARE) rose 45.2% to $3.08 in pre-market trading after the company reported the FDA approval of XACIATO Vaginal Gel as a treatment...
Via
Benzinga
2 Big Stock Bets That Are Insiders Are Buying Now
↗
December 06, 2021
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.
Via
InvestorPlace
Zomedica Stock Looks Tempting Here, But There’s Likely More Downside
↗
December 03, 2021
Early in 2021, ZOM stock was part of the meme stock trade, but recent catalysts suggest it may be moving toward investment territory.
Via
InvestorPlace
Zomedica Is Languishing Today, but Keep an Eye on This Risky Play
↗
November 17, 2021
It's a risky play no doubt, but ZOM stock stands to get out of its current rut as a key temporary issue subsides.
Via
InvestorPlace
Zomedica Announces Third Quarter 2021 Financial Results
November 12, 2021
ANN ARBOR, MI / ACCESSWIRE / November 12, 2021 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats,...
From
Zomedica Corp.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
7 Penny Stocks That Could Have an Explosive Year-End
↗
November 05, 2021
While meme trends are on the wane, these seven penny stocks still stand to make turbocharged moves higher in the short-term.
Via
InvestorPlace
Pet Stocks Alert: What Is Going on With PETZ and ZOM Stocks Today?
↗
November 04, 2021
Speculative pet stocks TDH Holdings and Zomedica are jumping higher in morning trading but investors should be skeptical of the moves.
Via
InvestorPlace
6 of the Hottest Stocks to Pick Up for Less Than $1
↗
November 01, 2021
These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals.
Via
InvestorPlace
Stay Away From Zomedica for These 3 Key Reasons
↗
October 25, 2021
ZOM stock had its best days in early 2021, but now its weak financial performance fully justifies its price weakness.
Via
InvestorPlace
Zomedica Management Finally Delivers Some Good News
↗
October 21, 2021
Zomedica's acquisition is precisely what was needed to get ZOM stock out of its lethargy. Long-term, it could be a game-changer. Here’s why.
Via
InvestorPlace
Zomedica Stock Will Need More Than a Change in Management to Bounce Back
↗
October 13, 2021
If the economy falters, past precedent looms ominously for ZOM stock.
Via
InvestorPlace
Topics
Economy
New CEO and Acquisition Could Breathe New Life Into Zomedica
↗
October 11, 2021
A turnaround in ZOM stock may happen sooner rather than later as Zomedica undergoes an executive-level change and builds out its business.
Via
InvestorPlace
Zomedica Has Potential, but It’s Far Too Expensive for Now
↗
October 07, 2021
ZOM stock can be a pet care industry leader, but it needs to make significant improvements before becoming a solid long-term play.
Via
InvestorPlace
The Challenges for Zomedica Continue, But It Still Has Huge Potential
↗
October 07, 2021
Patience is key with this name, but as it still stands to grab a piece of a multi-billion dollar market, ZOM stock remains worth the risk.
Via
InvestorPlace
3 Hot Penny Stocks: Why ZOM, AEZS and PROG Are Seeing Big Gains Today
↗
October 01, 2021
A few hot penny stocks are seeing major movement on Friday as shares ride higher and we've got all the details traders need.
Via
InvestorPlace
ZOM Stock: There’s a $71 Million Reason Zomedica Is Gaining Today
↗
October 01, 2021
ZOM stock is up big today on news of a big merger. The company is acquiring proven vet tech outfit PulseVet in an all-cash deal.
Via
InvestorPlace
Why Zomedica Shares Are Soaring Today
↗
October 01, 2021
Zomedica Corp (AMEX:ZOM) is trading significantly higher Friday after the company announced the purchase of Pulse Veterinary Technologies for $70.9 million in cash and stock...
Via
Benzinga
With the Crickets Chirping at Zomedica HQ, Why Buy the Stock?
↗
September 24, 2021
The only word out of Zomedica in September was its announcement of a new director. That’s not the news ZOM stock needs right now.
Via
InvestorPlace
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
